ALX Oncology
ALXO
ALXO
86 hedge funds and large institutions have $161M invested in ALX Oncology in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.02% less ownership
Funds ownership: 89.39% → 87.37% (-2%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
61% less capital invested
Capital invested by funds: $410M → $161M (-$248M)
Holders
86
Holding in Top 10
1
Calls
$80K
Puts
$1K
Top Buyers
| 1 | +$4.48M | |
| 2 | +$459K | |
| 3 | +$373K | |
| 4 |
Squarepoint
New York
|
+$286K |
| 5 |
Two Sigma Investments
New York
|
+$282K |
Top Sellers
| 1 | -$3.84M | |
| 2 | -$3.06M | |
| 3 | -$1.76M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.07M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$803K |